Yunru Tian
Chengdu, 610041, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Machine learning model integrating oral microbiota and clinical features for predicting osteoporosis and bone loss in high-altitude populations.
Journal: BMC microbiology
Published: September 16, 2025
Repurposed drug agomelatine is therapeutic against collagen-induced arthritis via iNOS targeting.
Journal: International immunopharmacology
Published: December 03, 2023
Macrophage-derived mir-100-5p orchestrates synovial proliferation and inflammation in rheumatoid arthritis through mTOR signaling.
Journal: Journal of nanobiotechnology
Published: September 06, 2023
Targeting glycolytic pathway in fibroblast-like synoviocytes for rheumatoid arthritis therapy: challenges and opportunities.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: April 08, 2023
Fexofenadine protects against lipopolysaccharide-induced acute lung injury by targeting cytosolic phospholipase A2.
Journal: International immunopharmacology
Published: September 27, 2022
Clinical value of YKL-40 in patients with polymyositis/dermatomyositis: A cross-sectional study and a systematic review.
Journal: Journal of clinical laboratory analysis
Published: March 17, 2022
Effects of medications on incidence and risk of knee and hip joint replacement in patients with osteoarthritis: a systematic review and meta-analysis.
Journal: Advances in rheumatology (London, England)
Published: January 26, 2022
Serum levels of periostin are decreased in patients with dermatomyositis.
Journal: Rheumatology (Oxford, England)
Published: October 14, 2021
Neoplasm Risk in Patients With Rheumatoid Arthritis Treated With Fostamatinib: A Systematic Review and Meta-analysis.
Journal: Frontiers in pharmacology
Published: September 01, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026